DLA Piper has advised China International Capital Corporation Hong Kong Securities Limited. Cooley has advised Shanghai Seer Intelligent Technology Co., Ltd. (SEER Robotics). Shanghai Seer Intelligent...
Shanghai Seer Intelligent Technology Completes HKD1.067 Billion IPO and Hong Kong Listing
Circuit Fabology Microelectronics Equipment Completes US$383 Million Hong Kong IPO
Clifford Chance, Ashurst, and DLA Piper have advised Circuit Fabology Microelectronics Equipment Co., Ltd. on its initial public offering and listing on the Main Board of...
NewBX Secures VATP Licence from Hong Kong SFC
DLA Piper has advised NewBX Limited. NewBX Limited has successfully obtained a virtual asset trading platform (VATP) licence under the Hong Kong Securities and Futures Commission...
Ximei Resources Raises HKD537.2 Million Through Share Placement and Subscription
DLA Piper has advised Macquarie Capital Limited, China International Capital Corporation Hong Kong Securities Limited, and Haitong International Securities Company Limited as joint placing agents. Ximei...
Star Sports Medicine Completes Landmark Hong Kong IPO and Listing
Clifford Chance has advised Star Sports Medicine Co., Ltd. DLA Piper and Shanghai Kaiman Law Firm have advised CITIC Securities (Hong Kong) Limited and CCB International...
Xuanzhu Biopharm Completes Spin-off and Separate Listing on Hong Kong Stock Exchange
Kirkland & Ellis has advised Sihuan Pharmaceutical Holdings Group Ltd. and Xuanzhu Biopharmaceutical Co., Ltd. on the deals. Sihuan Pharmaceutical Holdings Group Ltd. and its subsidiary...
Acotec Scientific Holdings Limited’s HK$1.529 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
Shanghai HeartCare Medial Technology Corporation Limited’s HK$1.13 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Shanghai HeartCare Medial Technology Corporation Limited (06609.HK) on its mainboard listing on the Stock Exchange of Hong Kong. O’Melveny & Myers...
Brii Biosciences’ US$318 Million Hong Kong IPO
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
UNQ Holdings Limited’s US$46.86 Million Initial Public Offering
Herbert Smith Freehills has advised CICC on the deal. UNQ Holdings Limited (02177.HK) has been listed on the Stock Exchange of Hong Kong. CICC acted as sole...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....